Global Human Milk Oligosaccharides (HMO) Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
Summary
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
According to APO Research, The global Human Milk Oligosaccharides (HMO) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Human Milk Oligosaccharides (HMO) include Abbott, Inbiose, Glycom, Chr. Hansen (Jennewein), Elicityl SA, ZuChem and Dextra Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Human Milk Oligosaccharides (HMO), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Human Milk Oligosaccharides (HMO), also provides the sales of main regions and countries. Of the upcoming market potential for Human Milk Oligosaccharides (HMO), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human Milk Oligosaccharides (HMO) sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Human Milk Oligosaccharides (HMO) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Human Milk Oligosaccharides (HMO) sales, projected growth trends, production technology, application and end-user industry.
Human Milk Oligosaccharides (HMO) segment by Company
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Milk Oligosaccharides (HMO) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Milk Oligosaccharides (HMO) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Milk Oligosaccharides (HMO).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Human Milk Oligosaccharides (HMO) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Milk Oligosaccharides (HMO) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Milk Oligosaccharides (HMO) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Human Milk Oligosaccharides (HMO) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
According to APO Research, The global Human Milk Oligosaccharides (HMO) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Human Milk Oligosaccharides (HMO) include Abbott, Inbiose, Glycom, Chr. Hansen (Jennewein), Elicityl SA, ZuChem and Dextra Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Human Milk Oligosaccharides (HMO), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Human Milk Oligosaccharides (HMO), also provides the sales of main regions and countries. Of the upcoming market potential for Human Milk Oligosaccharides (HMO), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human Milk Oligosaccharides (HMO) sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Human Milk Oligosaccharides (HMO) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Human Milk Oligosaccharides (HMO) sales, projected growth trends, production technology, application and end-user industry.
Human Milk Oligosaccharides (HMO) segment by Company
- Abbott
- Inbiose
- Glycom
- Chr. Hansen (Jennewein)
- Elicityl SA
- ZuChem
- Dextra Laboratories
- 2'-FL & 3-FL
- Sialyllactose
- LNT & LNnT
- Infant Formula
- Functional Food & Beverages
- Food/Medical Supplements
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Milk Oligosaccharides (HMO) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Milk Oligosaccharides (HMO) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Milk Oligosaccharides (HMO).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Human Milk Oligosaccharides (HMO) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Milk Oligosaccharides (HMO) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Milk Oligosaccharides (HMO) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Human Milk Oligosaccharides (HMO) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Human Milk Oligosaccharides (HMO) Market Size, 2019 VS 2023 VS 2030
1.3 Global Human Milk Oligosaccharides (HMO) Market Size Estimates and Forecasts (2019-2030)
1.4 Global Human Milk Oligosaccharides (HMO) Sales Estimates and Forecasts (2019-2030)
1.5 Global Human Milk Oligosaccharides (HMO) Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET DYNAMICS
2.1 Human Milk Oligosaccharides (HMO) Industry Trends
2.2 Human Milk Oligosaccharides (HMO) Industry Drivers
2.3 Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges
2.4 Human Milk Oligosaccharides (HMO) Industry Restraints
3 HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET BY MANUFACTURERS
3.1 Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturers (2019-2024)
3.2 Global Human Milk Oligosaccharides (HMO) Sales by Manufacturers (2019-2024)
3.3 Global Human Milk Oligosaccharides (HMO) Average Sales Price by Manufacturers (2019-2024)
3.4 Global Human Milk Oligosaccharides (HMO) Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Human Milk Oligosaccharides (HMO) Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Human Milk Oligosaccharides (HMO) Manufacturers, Product Type & Application
3.7 Global Human Milk Oligosaccharides (HMO) Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Human Milk Oligosaccharides (HMO) Market CR5 and HHI
3.8.2 Global Top 5 and 10 Human Milk Oligosaccharides (HMO) Players Market Share by Revenue in 2023
3.8.3 2023 Human Milk Oligosaccharides (HMO) Tier 1, Tier 2, and Tier
4 HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET BY TYPE
4.1 Human Milk Oligosaccharides (HMO) Type Introduction
4.1.1 2'-FL & 3-FL
4.1.2 Sialyllactose
4.1.3 LNT & LNnT
4.2 Global Human Milk Oligosaccharides (HMO) Sales by Type
4.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Human Milk Oligosaccharides (HMO) Sales by Type (2019-2030)
4.2.3 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2019-2030)
4.3 Global Human Milk Oligosaccharides (HMO) Revenue by Type
4.3.1 Global Human Milk Oligosaccharides (HMO) Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2030)
4.3.3 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2019-2030)
5 HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET BY APPLICATION
5.1 Human Milk Oligosaccharides (HMO) Application Introduction
5.1.1 Infant Formula
5.1.2 Functional Food & Beverages
5.1.3 Food/Medical Supplements
5.1.4 Others
5.2 Global Human Milk Oligosaccharides (HMO) Sales by Application
5.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Human Milk Oligosaccharides (HMO) Sales by Application (2019-2030)
5.2.3 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2019-2030)
5.3 Global Human Milk Oligosaccharides (HMO) Revenue by Application
5.3.1 Global Human Milk Oligosaccharides (HMO) Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2030)
5.3.3 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2019-2030)
6 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) SALES BY REGION
6.1 Global Human Milk Oligosaccharides (HMO) Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Human Milk Oligosaccharides (HMO) Sales by Region (2019-2030)
6.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Region (2019-2024)
6.2.2 Global Human Milk Oligosaccharides (HMO) Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) REVENUE BY REGION
7.1 Global Human Milk Oligosaccharides (HMO) Revenue by Region
7.1.1 Global Human Milk Oligosaccharides (HMO) Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Human Milk Oligosaccharides (HMO) Revenue by Region (2019-2024)
7.1.3 Global Human Milk Oligosaccharides (HMO) Revenue by Region (2025-2030)
7.1.4 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Human Milk Oligosaccharides (HMO) Revenue (2019-2030)
7.2.2 North America Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Human Milk Oligosaccharides (HMO) Revenue (2019-2030)
7.3.2 Europe Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Revenue (2019-2030)
7.4.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Human Milk Oligosaccharides (HMO) Revenue (2019-2030)
7.5.2 LAMEA Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Abbott
8.1.1 Abbott Comapny Information
8.1.2 Abbott Business Overview
8.1.3 Abbott Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Abbott Human Milk Oligosaccharides (HMO) Product Portfolio
8.1.5 Abbott Recent Developments
8.2 Inbiose
8.2.1 Inbiose Comapny Information
8.2.2 Inbiose Business Overview
8.2.3 Inbiose Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 Inbiose Human Milk Oligosaccharides (HMO) Product Portfolio
8.2.5 Inbiose Recent Developments
8.3 Glycom
8.3.1 Glycom Comapny Information
8.3.2 Glycom Business Overview
8.3.3 Glycom Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Glycom Human Milk Oligosaccharides (HMO) Product Portfolio
8.3.5 Glycom Recent Developments
8.4 Chr. Hansen (Jennewein)
8.4.1 Chr. Hansen (Jennewein) Comapny Information
8.4.2 Chr. Hansen (Jennewein) Business Overview
8.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Portfolio
8.4.5 Chr. Hansen (Jennewein) Recent Developments
8.5 Elicityl SA
8.5.1 Elicityl SA Comapny Information
8.5.2 Elicityl SA Business Overview
8.5.3 Elicityl SA Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Elicityl SA Human Milk Oligosaccharides (HMO) Product Portfolio
8.5.5 Elicityl SA Recent Developments
8.6 ZuChem
8.6.1 ZuChem Comapny Information
8.6.2 ZuChem Business Overview
8.6.3 ZuChem Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 ZuChem Human Milk Oligosaccharides (HMO) Product Portfolio
8.6.5 ZuChem Recent Developments
8.7 Dextra Laboratories
8.7.1 Dextra Laboratories Comapny Information
8.7.2 Dextra Laboratories Business Overview
8.7.3 Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Portfolio
8.7.5 Dextra Laboratories Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Human Milk Oligosaccharides (HMO) Value Chain Analysis
9.1.1 Human Milk Oligosaccharides (HMO) Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Human Milk Oligosaccharides (HMO) Production Mode & Process
9.2 Human Milk Oligosaccharides (HMO) Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Human Milk Oligosaccharides (HMO) Distributors
9.2.3 Human Milk Oligosaccharides (HMO) Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
1.1 Product Definition
1.2 Global Human Milk Oligosaccharides (HMO) Market Size, 2019 VS 2023 VS 2030
1.3 Global Human Milk Oligosaccharides (HMO) Market Size Estimates and Forecasts (2019-2030)
1.4 Global Human Milk Oligosaccharides (HMO) Sales Estimates and Forecasts (2019-2030)
1.5 Global Human Milk Oligosaccharides (HMO) Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET DYNAMICS
2.1 Human Milk Oligosaccharides (HMO) Industry Trends
2.2 Human Milk Oligosaccharides (HMO) Industry Drivers
2.3 Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges
2.4 Human Milk Oligosaccharides (HMO) Industry Restraints
3 HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET BY MANUFACTURERS
3.1 Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturers (2019-2024)
3.2 Global Human Milk Oligosaccharides (HMO) Sales by Manufacturers (2019-2024)
3.3 Global Human Milk Oligosaccharides (HMO) Average Sales Price by Manufacturers (2019-2024)
3.4 Global Human Milk Oligosaccharides (HMO) Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Human Milk Oligosaccharides (HMO) Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Human Milk Oligosaccharides (HMO) Manufacturers, Product Type & Application
3.7 Global Human Milk Oligosaccharides (HMO) Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Human Milk Oligosaccharides (HMO) Market CR5 and HHI
3.8.2 Global Top 5 and 10 Human Milk Oligosaccharides (HMO) Players Market Share by Revenue in 2023
3.8.3 2023 Human Milk Oligosaccharides (HMO) Tier 1, Tier 2, and Tier
4 HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET BY TYPE
4.1 Human Milk Oligosaccharides (HMO) Type Introduction
4.1.1 2'-FL & 3-FL
4.1.2 Sialyllactose
4.1.3 LNT & LNnT
4.2 Global Human Milk Oligosaccharides (HMO) Sales by Type
4.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Human Milk Oligosaccharides (HMO) Sales by Type (2019-2030)
4.2.3 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2019-2030)
4.3 Global Human Milk Oligosaccharides (HMO) Revenue by Type
4.3.1 Global Human Milk Oligosaccharides (HMO) Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2030)
4.3.3 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2019-2030)
5 HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET BY APPLICATION
5.1 Human Milk Oligosaccharides (HMO) Application Introduction
5.1.1 Infant Formula
5.1.2 Functional Food & Beverages
5.1.3 Food/Medical Supplements
5.1.4 Others
5.2 Global Human Milk Oligosaccharides (HMO) Sales by Application
5.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Human Milk Oligosaccharides (HMO) Sales by Application (2019-2030)
5.2.3 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2019-2030)
5.3 Global Human Milk Oligosaccharides (HMO) Revenue by Application
5.3.1 Global Human Milk Oligosaccharides (HMO) Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2030)
5.3.3 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2019-2030)
6 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) SALES BY REGION
6.1 Global Human Milk Oligosaccharides (HMO) Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Human Milk Oligosaccharides (HMO) Sales by Region (2019-2030)
6.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Region (2019-2024)
6.2.2 Global Human Milk Oligosaccharides (HMO) Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) REVENUE BY REGION
7.1 Global Human Milk Oligosaccharides (HMO) Revenue by Region
7.1.1 Global Human Milk Oligosaccharides (HMO) Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Human Milk Oligosaccharides (HMO) Revenue by Region (2019-2024)
7.1.3 Global Human Milk Oligosaccharides (HMO) Revenue by Region (2025-2030)
7.1.4 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Human Milk Oligosaccharides (HMO) Revenue (2019-2030)
7.2.2 North America Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Human Milk Oligosaccharides (HMO) Revenue (2019-2030)
7.3.2 Europe Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Revenue (2019-2030)
7.4.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Human Milk Oligosaccharides (HMO) Revenue (2019-2030)
7.5.2 LAMEA Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Abbott
8.1.1 Abbott Comapny Information
8.1.2 Abbott Business Overview
8.1.3 Abbott Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Abbott Human Milk Oligosaccharides (HMO) Product Portfolio
8.1.5 Abbott Recent Developments
8.2 Inbiose
8.2.1 Inbiose Comapny Information
8.2.2 Inbiose Business Overview
8.2.3 Inbiose Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 Inbiose Human Milk Oligosaccharides (HMO) Product Portfolio
8.2.5 Inbiose Recent Developments
8.3 Glycom
8.3.1 Glycom Comapny Information
8.3.2 Glycom Business Overview
8.3.3 Glycom Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Glycom Human Milk Oligosaccharides (HMO) Product Portfolio
8.3.5 Glycom Recent Developments
8.4 Chr. Hansen (Jennewein)
8.4.1 Chr. Hansen (Jennewein) Comapny Information
8.4.2 Chr. Hansen (Jennewein) Business Overview
8.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Portfolio
8.4.5 Chr. Hansen (Jennewein) Recent Developments
8.5 Elicityl SA
8.5.1 Elicityl SA Comapny Information
8.5.2 Elicityl SA Business Overview
8.5.3 Elicityl SA Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Elicityl SA Human Milk Oligosaccharides (HMO) Product Portfolio
8.5.5 Elicityl SA Recent Developments
8.6 ZuChem
8.6.1 ZuChem Comapny Information
8.6.2 ZuChem Business Overview
8.6.3 ZuChem Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 ZuChem Human Milk Oligosaccharides (HMO) Product Portfolio
8.6.5 ZuChem Recent Developments
8.7 Dextra Laboratories
8.7.1 Dextra Laboratories Comapny Information
8.7.2 Dextra Laboratories Business Overview
8.7.3 Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Portfolio
8.7.5 Dextra Laboratories Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Human Milk Oligosaccharides (HMO) Value Chain Analysis
9.1.1 Human Milk Oligosaccharides (HMO) Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Human Milk Oligosaccharides (HMO) Production Mode & Process
9.2 Human Milk Oligosaccharides (HMO) Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Human Milk Oligosaccharides (HMO) Distributors
9.2.3 Human Milk Oligosaccharides (HMO) Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
LIST OF TABLES
Table 1. Human Milk Oligosaccharides (HMO) Industry Trends
Table 2. Human Milk Oligosaccharides (HMO) Industry Drivers
Table 3. Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges
Table 4. Human Milk Oligosaccharides (HMO) Industry Restraints
Table 5. Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Human Milk Oligosaccharides (HMO) Sales by Manufacturers (Tons) & (2019-2024)
Table 8. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Manufacturers
Table 9. Global Human Milk Oligosaccharides (HMO) Average Sales Price (USD/Ton) of Manufacturers (2019-2024)
Table 10. Global Human Milk Oligosaccharides (HMO) Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Human Milk Oligosaccharides (HMO) Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Human Milk Oligosaccharides (HMO) Manufacturers, Product Type & Application
Table 13. Global Human Milk Oligosaccharides (HMO) Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Human Milk Oligosaccharides (HMO) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of 2'-FL & 3-FL
Table 17. Major Manufacturers of Sialyllactose
Table 18. Major Manufacturers of LNT & LNnT
Table 19. Global Human Milk Oligosaccharides (HMO) Sales by Type 2019 VS 2023 VS 2030 (Tons)
Table 20. Global Human Milk Oligosaccharides (HMO) Sales by Type (2019-2024) & (Tons)
Table 21. Global Human Milk Oligosaccharides (HMO) Sales by Type (2025-2030) & (Tons)
Table 22. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2019-2024)
Table 23. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2025-2030)
Table 24. Global Human Milk Oligosaccharides (HMO) Revenue by Type 2019 VS 2023 VS 2030 (Tons)
Table 25. Global Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2024) & (Tons)
Table 26. Global Human Milk Oligosaccharides (HMO) Revenue by Type (2025-2030) & (Tons)
Table 27. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2019-2024)
Table 28. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2025-2030)
Table 29. Major Manufacturers of Infant Formula
Table 30. Major Manufacturers of Functional Food & Beverages
Table 31. Major Manufacturers of Food/Medical Supplements
Table 32. Major Manufacturers of Others
Table 33. Global Human Milk Oligosaccharides (HMO) Sales by Application 2019 VS 2023 VS 2030 (Tons)
Table 34. Global Human Milk Oligosaccharides (HMO) Sales by Application (2019-2024) & (Tons)
Table 35. Global Human Milk Oligosaccharides (HMO) Sales by Application (2025-2030) & (Tons)
Table 36. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2019-2024)
Table 37. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2025-2030)
Table 38. Global Human Milk Oligosaccharides (HMO) Revenue by Application 2019 VS 2023 VS 2030 (Tons)
Table 39. Global Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2024) & (Tons)
Table 40. Global Human Milk Oligosaccharides (HMO) Revenue by Application (2025-2030) & (Tons)
Table 41. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2019-2024)
Table 42. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2025-2030)
Table 43. Global Human Milk Oligosaccharides (HMO) Sales by Region: 2019 VS 2023 VS 2030 (Tons)
Table 44. Global Human Milk Oligosaccharides (HMO) Sales by Region (2019-2024) & (Tons)
Table 45. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2019-2024)
Table 46. Global Human Milk Oligosaccharides (HMO) Sales Forecasted by Region (2025-2030) & (Tons)
Table 47. Global Human Milk Oligosaccharides (HMO) Sales Forecasted Market Share by Region (2025-2030)
Table 48. North America Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 49. North America Human Milk Oligosaccharides (HMO) Sales by Country (2019-2024) & (Tons)
Table 50. North America Human Milk Oligosaccharides (HMO) Sales by Country (2025-2030) & (Tons)
Table 51. Europe Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 52. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2019-2024) & (Tons)
Table 53. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2025-2030) & (Tons)
Table 54. Asia Pacific Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 55. Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Country (2019-2024) & (Tons)
Table 56. Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Country (2025-2030) & (Tons)
Table 57. LAMEA Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 58. LAMEA Human Milk Oligosaccharides (HMO) Sales by Country (2019-2024) & (Tons)
Table 59. LAMEA Human Milk Oligosaccharides (HMO) Sales by Country (2025-2030) & (Tons)
Table 60. Global Human Milk Oligosaccharides (HMO) Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 61. Global Human Milk Oligosaccharides (HMO) Revenue by Region (2019-2024) & (US$ Million)
Table 62. Global Human Milk Oligosaccharides (HMO) Revenue by Region (2025-2030) & (US$ Million)
Table 63. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2019-2024)
Table 64. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2025-2030)
Table 65. Abbott Company Information
Table 66. Abbott Business Overview
Table 67. Abbott Human Milk Oligosaccharides (HMO) Sales (Tons), Price (USD/Ton), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 68. Abbott Human Milk Oligosaccharides (HMO) Product Portfolio
Table 69. Abbott Recent Development
Table 70. Inbiose Company Information
Table 71. Inbiose Business Overview
Table 72. Inbiose Human Milk Oligosaccharides (HMO) Sales (Tons), Price (USD/Ton), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 73. Inbiose Human Milk Oligosaccharides (HMO) Product Portfolio
Table 74. Inbiose Recent Development
Table 75. Glycom Company Information
Table 76. Glycom Business Overview
Table 77. Glycom Human Milk Oligosaccharides (HMO) Sales (Tons), Price (USD/Ton), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 78. Glycom Human Milk Oligosaccharides (HMO) Product Portfolio
Table 79. Glycom Recent Development
Table 80. Chr. Hansen (Jennewein) Company Information
Table 81. Chr. Hansen (Jennewein) Business Overview
Table 82. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales (Tons), Price (USD/Ton), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 83. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Portfolio
Table 84. Chr. Hansen (Jennewein) Recent Development
Table 85. Elicityl SA Company Information
Table 86. Elicityl SA Business Overview
Table 87. Elicityl SA Human Milk Oligosaccharides (HMO) Sales (Tons), Price (USD/Ton), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 88. Elicityl SA Human Milk Oligosaccharides (HMO) Product Portfolio
Table 89. Elicityl SA Recent Development
Table 90. ZuChem Company Information
Table 91. ZuChem Business Overview
Table 92. ZuChem Human Milk Oligosaccharides (HMO) Sales (Tons), Price (USD/Ton), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 93. ZuChem Human Milk Oligosaccharides (HMO) Product Portfolio
Table 94. ZuChem Recent Development
Table 95. Dextra Laboratories Company Information
Table 96. Dextra Laboratories Business Overview
Table 97. Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales (Tons), Price (USD/Ton), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 98. Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Portfolio
Table 99. Dextra Laboratories Recent Development
Table 100. Key Raw Materials
Table 101. Raw Materials Key Suppliers
Table 102. Human Milk Oligosaccharides (HMO) Distributors List
Table 103. Human Milk Oligosaccharides (HMO) Customers List
Table 104. Research Programs/Design for This Report
Table 105. Authors List of This Report
Table 106. Secondary Sources
Table 107. Primary Sources
Table 1. Human Milk Oligosaccharides (HMO) Industry Trends
Table 2. Human Milk Oligosaccharides (HMO) Industry Drivers
Table 3. Human Milk Oligosaccharides (HMO) Industry Opportunities and Challenges
Table 4. Human Milk Oligosaccharides (HMO) Industry Restraints
Table 5. Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Human Milk Oligosaccharides (HMO) Sales by Manufacturers (Tons) & (2019-2024)
Table 8. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Manufacturers
Table 9. Global Human Milk Oligosaccharides (HMO) Average Sales Price (USD/Ton) of Manufacturers (2019-2024)
Table 10. Global Human Milk Oligosaccharides (HMO) Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Human Milk Oligosaccharides (HMO) Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Human Milk Oligosaccharides (HMO) Manufacturers, Product Type & Application
Table 13. Global Human Milk Oligosaccharides (HMO) Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Human Milk Oligosaccharides (HMO) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of 2'-FL & 3-FL
Table 17. Major Manufacturers of Sialyllactose
Table 18. Major Manufacturers of LNT & LNnT
Table 19. Global Human Milk Oligosaccharides (HMO) Sales by Type 2019 VS 2023 VS 2030 (Tons)
Table 20. Global Human Milk Oligosaccharides (HMO) Sales by Type (2019-2024) & (Tons)
Table 21. Global Human Milk Oligosaccharides (HMO) Sales by Type (2025-2030) & (Tons)
Table 22. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2019-2024)
Table 23. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2025-2030)
Table 24. Global Human Milk Oligosaccharides (HMO) Revenue by Type 2019 VS 2023 VS 2030 (Tons)
Table 25. Global Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2024) & (Tons)
Table 26. Global Human Milk Oligosaccharides (HMO) Revenue by Type (2025-2030) & (Tons)
Table 27. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2019-2024)
Table 28. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2025-2030)
Table 29. Major Manufacturers of Infant Formula
Table 30. Major Manufacturers of Functional Food & Beverages
Table 31. Major Manufacturers of Food/Medical Supplements
Table 32. Major Manufacturers of Others
Table 33. Global Human Milk Oligosaccharides (HMO) Sales by Application 2019 VS 2023 VS 2030 (Tons)
Table 34. Global Human Milk Oligosaccharides (HMO) Sales by Application (2019-2024) & (Tons)
Table 35. Global Human Milk Oligosaccharides (HMO) Sales by Application (2025-2030) & (Tons)
Table 36. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2019-2024)
Table 37. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2025-2030)
Table 38. Global Human Milk Oligosaccharides (HMO) Revenue by Application 2019 VS 2023 VS 2030 (Tons)
Table 39. Global Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2024) & (Tons)
Table 40. Global Human Milk Oligosaccharides (HMO) Revenue by Application (2025-2030) & (Tons)
Table 41. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2019-2024)
Table 42. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2025-2030)
Table 43. Global Human Milk Oligosaccharides (HMO) Sales by Region: 2019 VS 2023 VS 2030 (Tons)
Table 44. Global Human Milk Oligosaccharides (HMO) Sales by Region (2019-2024) & (Tons)
Table 45. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2019-2024)
Table 46. Global Human Milk Oligosaccharides (HMO) Sales Forecasted by Region (2025-2030) & (Tons)
Table 47. Global Human Milk Oligosaccharides (HMO) Sales Forecasted Market Share by Region (2025-2030)
Table 48. North America Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 49. North America Human Milk Oligosaccharides (HMO) Sales by Country (2019-2024) & (Tons)
Table 50. North America Human Milk Oligosaccharides (HMO) Sales by Country (2025-2030) & (Tons)
Table 51. Europe Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 52. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2019-2024) & (Tons)
Table 53. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2025-2030) & (Tons)
Table 54. Asia Pacific Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 55. Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Country (2019-2024) & (Tons)
Table 56. Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Country (2025-2030) & (Tons)
Table 57. LAMEA Human Milk Oligosaccharides (HMO) Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 58. LAMEA Human Milk Oligosaccharides (HMO) Sales by Country (2019-2024) & (Tons)
Table 59. LAMEA Human Milk Oligosaccharides (HMO) Sales by Country (2025-2030) & (Tons)
Table 60. Global Human Milk Oligosaccharides (HMO) Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 61. Global Human Milk Oligosaccharides (HMO) Revenue by Region (2019-2024) & (US$ Million)
Table 62. Global Human Milk Oligosaccharides (HMO) Revenue by Region (2025-2030) & (US$ Million)
Table 63. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2019-2024)
Table 64. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2025-2030)
Table 65. Abbott Company Information
Table 66. Abbott Business Overview
Table 67. Abbott Human Milk Oligosaccharides (HMO) Sales (Tons), Price (USD/Ton), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 68. Abbott Human Milk Oligosaccharides (HMO) Product Portfolio
Table 69. Abbott Recent Development
Table 70. Inbiose Company Information
Table 71. Inbiose Business Overview
Table 72. Inbiose Human Milk Oligosaccharides (HMO) Sales (Tons), Price (USD/Ton), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 73. Inbiose Human Milk Oligosaccharides (HMO) Product Portfolio
Table 74. Inbiose Recent Development
Table 75. Glycom Company Information
Table 76. Glycom Business Overview
Table 77. Glycom Human Milk Oligosaccharides (HMO) Sales (Tons), Price (USD/Ton), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 78. Glycom Human Milk Oligosaccharides (HMO) Product Portfolio
Table 79. Glycom Recent Development
Table 80. Chr. Hansen (Jennewein) Company Information
Table 81. Chr. Hansen (Jennewein) Business Overview
Table 82. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales (Tons), Price (USD/Ton), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 83. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Portfolio
Table 84. Chr. Hansen (Jennewein) Recent Development
Table 85. Elicityl SA Company Information
Table 86. Elicityl SA Business Overview
Table 87. Elicityl SA Human Milk Oligosaccharides (HMO) Sales (Tons), Price (USD/Ton), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 88. Elicityl SA Human Milk Oligosaccharides (HMO) Product Portfolio
Table 89. Elicityl SA Recent Development
Table 90. ZuChem Company Information
Table 91. ZuChem Business Overview
Table 92. ZuChem Human Milk Oligosaccharides (HMO) Sales (Tons), Price (USD/Ton), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 93. ZuChem Human Milk Oligosaccharides (HMO) Product Portfolio
Table 94. ZuChem Recent Development
Table 95. Dextra Laboratories Company Information
Table 96. Dextra Laboratories Business Overview
Table 97. Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales (Tons), Price (USD/Ton), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 98. Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Portfolio
Table 99. Dextra Laboratories Recent Development
Table 100. Key Raw Materials
Table 101. Raw Materials Key Suppliers
Table 102. Human Milk Oligosaccharides (HMO) Distributors List
Table 103. Human Milk Oligosaccharides (HMO) Customers List
Table 104. Research Programs/Design for This Report
Table 105. Authors List of This Report
Table 106. Secondary Sources
Table 107. Primary Sources
LIST OF FIGURES
Figure 1. Human Milk Oligosaccharides (HMO) Product Picture
Figure 2. Global Human Milk Oligosaccharides (HMO) Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Human Milk Oligosaccharides (HMO) Market Size (2019-2030) & (US$ Million)
Figure 4. Global Human Milk Oligosaccharides (HMO) Sales (2019-2030) & (Tons)
Figure 5. Global Human Milk Oligosaccharides (HMO) Average Price (USD/Ton) & (2019-2030)
Figure 6. Global Top 5 and 10 Human Milk Oligosaccharides (HMO) Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. 2'-FL & 3-FL Picture
Figure 9. Sialyllactose Picture
Figure 10. LNT & LNnT Picture
Figure 11. Global Human Milk Oligosaccharides (HMO) Sales by Type (2019 VS 2023 VS 2030) & (Tons)
Figure 12. Global Human Milk Oligosaccharides (HMO) Sales Market Share 2019 VS 2023 VS 2030
Figure 13. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2019-2030)
Figure 14. Global Human Milk Oligosaccharides (HMO) Revenue by Type (2019 VS 2023 VS 2030) & (Tons)
Figure 15. Global Human Milk Oligosaccharides (HMO) Revenue Market Share 2019 VS 2023 VS 2030
Figure 16. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2019-2030)
Figure 17. Infant Formula Picture
Figure 18. Functional Food & Beverages Picture
Figure 19. Food/Medical Supplements Picture
Figure 20. Others Picture
Figure 21. Global Human Milk Oligosaccharides (HMO) Sales by Application (2019 VS 2023 VS 2030) & (Tons)
Figure 22. Global Human Milk Oligosaccharides (HMO) Sales Market Share 2019 VS 2023 VS 2030
Figure 23. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2019-2030)
Figure 24. Global Human Milk Oligosaccharides (HMO) Revenue by Application (2019 VS 2023 VS 2030) & (Tons)
Figure 25. Global Human Milk Oligosaccharides (HMO) Revenue Market Share 2019 VS 2023 VS 2030
Figure 26. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2019-2030)
Figure 27. North America Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 28. North America Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2019-2030)
Figure 29. U.S. Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 30. Canada Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 31. Europe Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 32. Europe Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2019-2030)
Figure 33. Germany Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 34. France Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 35. U.K. Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 36. Italy Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 37. Netherlands Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 38. Asia Pacific Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 39. Asia Pacific Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2019-2030)
Figure 40. China Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 41. Japan Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 42. South Korea Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 43. Southeast Asia Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 44. India Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 45. Australia Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 46. LAMEA Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 47. LAMEA Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2019-2030)
Figure 48. Mexico Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 49. Brazil Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 50. Turkey Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 51. GCC Countries Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 52. Global Human Milk Oligosaccharides (HMO) Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 53. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 54. North America Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Figure 55. North America Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 56. Europe Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Figure 57. Europe Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 58. Asia-Pacific Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Figure 59. Asia-Pacific Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 60. LAMEA Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Figure 61. LAMEA Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 62. Human Milk Oligosaccharides (HMO) Value Chain
Figure 63. Manufacturing Cost Structure
Figure 64. Human Milk Oligosaccharides (HMO) Production Mode & Process
Figure 65. Direct Comparison with Distribution Share
Figure 66. Distributors Profiles
Figure 67. Years Considered
Figure 68. Research Process
Figure 69. Key Executives Interviewed
Figure 1. Human Milk Oligosaccharides (HMO) Product Picture
Figure 2. Global Human Milk Oligosaccharides (HMO) Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Human Milk Oligosaccharides (HMO) Market Size (2019-2030) & (US$ Million)
Figure 4. Global Human Milk Oligosaccharides (HMO) Sales (2019-2030) & (Tons)
Figure 5. Global Human Milk Oligosaccharides (HMO) Average Price (USD/Ton) & (2019-2030)
Figure 6. Global Top 5 and 10 Human Milk Oligosaccharides (HMO) Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. 2'-FL & 3-FL Picture
Figure 9. Sialyllactose Picture
Figure 10. LNT & LNnT Picture
Figure 11. Global Human Milk Oligosaccharides (HMO) Sales by Type (2019 VS 2023 VS 2030) & (Tons)
Figure 12. Global Human Milk Oligosaccharides (HMO) Sales Market Share 2019 VS 2023 VS 2030
Figure 13. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2019-2030)
Figure 14. Global Human Milk Oligosaccharides (HMO) Revenue by Type (2019 VS 2023 VS 2030) & (Tons)
Figure 15. Global Human Milk Oligosaccharides (HMO) Revenue Market Share 2019 VS 2023 VS 2030
Figure 16. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2019-2030)
Figure 17. Infant Formula Picture
Figure 18. Functional Food & Beverages Picture
Figure 19. Food/Medical Supplements Picture
Figure 20. Others Picture
Figure 21. Global Human Milk Oligosaccharides (HMO) Sales by Application (2019 VS 2023 VS 2030) & (Tons)
Figure 22. Global Human Milk Oligosaccharides (HMO) Sales Market Share 2019 VS 2023 VS 2030
Figure 23. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2019-2030)
Figure 24. Global Human Milk Oligosaccharides (HMO) Revenue by Application (2019 VS 2023 VS 2030) & (Tons)
Figure 25. Global Human Milk Oligosaccharides (HMO) Revenue Market Share 2019 VS 2023 VS 2030
Figure 26. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2019-2030)
Figure 27. North America Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 28. North America Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2019-2030)
Figure 29. U.S. Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 30. Canada Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 31. Europe Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 32. Europe Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2019-2030)
Figure 33. Germany Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 34. France Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 35. U.K. Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 36. Italy Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 37. Netherlands Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 38. Asia Pacific Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 39. Asia Pacific Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2019-2030)
Figure 40. China Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 41. Japan Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 42. South Korea Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 43. Southeast Asia Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 44. India Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 45. Australia Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 46. LAMEA Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 47. LAMEA Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2019-2030)
Figure 48. Mexico Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 49. Brazil Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 50. Turkey Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 51. GCC Countries Human Milk Oligosaccharides (HMO) Sales and Growth Rate (2019-2030) & (Tons)
Figure 52. Global Human Milk Oligosaccharides (HMO) Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 53. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 54. North America Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Figure 55. North America Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 56. Europe Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Figure 57. Europe Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 58. Asia-Pacific Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Figure 59. Asia-Pacific Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 60. LAMEA Human Milk Oligosaccharides (HMO) Revenue (2019-2030) & (US$ Million)
Figure 61. LAMEA Human Milk Oligosaccharides (HMO) Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 62. Human Milk Oligosaccharides (HMO) Value Chain
Figure 63. Manufacturing Cost Structure
Figure 64. Human Milk Oligosaccharides (HMO) Production Mode & Process
Figure 65. Direct Comparison with Distribution Share
Figure 66. Distributors Profiles
Figure 67. Years Considered
Figure 68. Research Process
Figure 69. Key Executives Interviewed
